Compound ID | 1347

Tridecaptin M

Class: Lipopeptide

Spectrum of activity: Gram-negative
Details of activity: Lipid II/Enterobacteriaceae
Institute where first reported: CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh, India
Year first mentioned: 2019
Highest developmental phase: Preclinical
Development status: Active
Chemical structure(s):
Click here for structure editor
Molecular weight: 1456.82
Iso. SMILES: CC[C@H](C)CCCCC(=O)NCC(=O)N[C@H](CCN)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC)C(=O)N[C@@H](CCN)CN[C@H](CCN)CN[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=C)N[C@@H](CO)C(=O)O
InChI Key: MNHWBPYJBDSDFA-SEQVZXRKSA-N
Can. SMILES: CC[C@H](C)CCCCC(=O)NCC(=O)N[C@H](CCN)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC)C(=O)N[C@@H](CCN)CN[C@H](CCN)CN[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=C)N[C@@H](CO)C(=O)O
InChI: InChI=1S/C70H121N17O16/c1-11-40(6)20-16-19-23-56(90)76-36-57(91)81-52(28-31-73)63(95)78-37-58(92)82-54(38-88)67(99)85-53(32-45-33-75-50-22-18-17-21-48(45)50)66(98)83-49(15-5)64(96)80-47(27-30-72)35-74-46(26-29-71)34-77-61(42(8)13-3)68(100)84-51(24-25-59(93)94)65(97)87-62(43(9)14-4)69(101)86-60(41(7)12-2)44(10)79-55(39-89)70(102)103/h17-18,21-22,33,40-43,46-47,49,51-55,60-62,74-75,77,79,88-89H,10-16,19-20,23-32,34-39,71-73H2,1-9H3,(H,76,90)(H,78,95)(H,80,96)(H,81,91)(H,82,92)(H,83,98)(H,84,100)(H,85,99)(H,86,101)(H,87,97)(H,93,94)(H,102,103)/t40-,41-,42-,43-,46+,47-,49-,51-,52+,53+,54+,55-,60+,61-,62-/m0/s1

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.